Vercherat C - Search Results

1

Neuropilin-2 contributes to tumor progression in preclinical models of small intestinal neuroendocrine tumors.

Bollard J, Patte C, Radkova K, Massoma P, Chardon L, Valantin J, Gadot N, Goddard I, Vercherat C, Hervieu V, Gouysse G, Poncet G, Scoazec JY, Walter T, Roche C. Bollard J, et al. Among authors: vercherat c. J Pathol. 2019 Nov;249(3):343-355. doi: 10.1002/path.5321. Epub 2019 Sep 3. J Pathol. 2019. PMID: 31257576

2

The axon guidance molecule semaphorin 3F is a negative regulator of tumor progression and proliferation in ileal neuroendocrine tumors.

Bollard J, Massoma P, Vercherat C, Blanc M, Lepinasse F, Gadot N, Couderc C, Poncet G, Walter T, Joly MO, Hervieu V, Scoazec JY, Roche C. Bollard J, et al. Among authors: vercherat c. Oncotarget. 2015 Nov 3;6(34):36731-45. doi: 10.18632/oncotarget.5481. Oncotarget. 2015. PMID: 26447612 Free PMC article.

3

mTOR inhibitors activate PERK signaling and favor viability of gastrointestinal neuroendocrine cell lines.

Freis P, Bollard J, Lebeau J, Massoma P, Fauvre J, Vercherat C, Walter T, Manié S, Roche C, Scoazec JY, Ferraro-Peyret C. Freis P, et al. Among authors: vercherat c. Oncotarget. 2017 Mar 28;8(13):20974-20987. doi: 10.18632/oncotarget.15469. Oncotarget. 2017. PMID: 28423496 Free PMC article.

4

VEGF secretion by neuroendocrine tumor cells is inhibited by octreotide and by inhibitors of the PI3K/AKT/mTOR pathway.

Villaume K, Blanc M, Gouysse G, Walter T, Couderc C, Nejjari M, Vercherat C, Cordier-Bussat M, Roche C, Scoazec JY. Villaume K, et al. Among authors: vercherat c. Neuroendocrinology. 2010;91(3):268-78. doi: 10.1159/000289569. Epub 2010 Apr 13. Neuroendocrinology. 2010. PMID: 20389030

5

Gemcitabine and oxaliplatin or alkylating agents for neuroendocrine tumors: Comparison of efficacy and search for predictive factors guiding treatment choice.

Dussol AS, Joly MO, Vercherat C, Forestier J, Hervieu V, Scoazec JY, Lombard-Bohas C, Walter T. Dussol AS, et al. Among authors: vercherat c. Cancer. 2015 Oct 1;121(19):3428-34. doi: 10.1002/cncr.29517. Epub 2015 Jun 8. Cancer. 2015. PMID: 26058464 Free article.

6

Prediction of response to everolimus in neuroendocrine tumors: evaluation of clinical, biological and histological factors.

Benslama N, Bollard J, Vercherat C, Massoma P, Roche C, Hervieu V, Peron J, Lombard-Bohas C, Scoazec JY, Walter T. Benslama N, et al. Among authors: vercherat c. Invest New Drugs. 2016 Oct;34(5):654-62. doi: 10.1007/s10637-016-0363-6. Epub 2016 May 26. Invest New Drugs. 2016. PMID: 27230034

7

Combinatorial Treatment with mTOR Inhibitors and Streptozotocin Leads to Synergistic In Vitro and In Vivo Antitumor Effects in Insulinoma Cells.

Bollard J, Patte C, Massoma P, Goddard I, Gadot N, Benslama N, Hervieu V, Ferraro-Peyret C, Cordier-Bussat M, Scoazec JY, Roche C, Walter T, Vercherat C. Bollard J, et al. Among authors: vercherat c. Mol Cancer Ther. 2018 Jan;17(1):60-72. doi: 10.1158/1535-7163.MCT-17-0325. Epub 2017 Oct 19. Mol Cancer Ther. 2018. PMID: 29051320

8

O6-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: prognostic relevance and association with response to alkylating agents.

Walter T, van Brakel B, Vercherat C, Hervieu V, Forestier J, Chayvialle JA, Molin Y, Lombard-Bohas C, Joly MO, Scoazec JY. Walter T, et al. Among authors: vercherat c. Br J Cancer. 2015 Feb 3;112(3):523-31. doi: 10.1038/bjc.2014.660. Epub 2015 Jan 13. Br J Cancer. 2015. PMID: 25584486 Free PMC article.

9

Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma.

Hamze Z, Vercherat C, Bernigaud-Lacheretz A, Bazzi W, Bonnavion R, Lu J, Calender A, Pouponnot C, Bertolino P, Roche C, Stein R, Scoazec JY, Zhang CX, Cordier-Bussat M. Hamze Z, et al. Among authors: vercherat c. Endocr Relat Cancer. 2013 Oct 24;20(6):833-48. doi: 10.1530/ERC-13-0164. Print 2013 Dec. Endocr Relat Cancer. 2013. PMID: 24157940 Free PMC article.

10

MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells.

Bazzi W, Renon M, Vercherat C, Hamze Z, Lacheretz-Bernigaud A, Wang H, Blanc M, Roche C, Calender A, Chayvialle JA, Scoazec JY, Cordier-Bussat M. Bazzi W, et al. Among authors: vercherat c. Gastroenterology. 2008 Nov;135(5):1698-1709.e2. doi: 10.1053/j.gastro.2008.07.031. Epub 2008 Jul 31. Gastroenterology. 2008. PMID: 18775714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page